Hongmei Jin

Title: Innovations of Hongmei Jin in Pharmaceutical Chemistry

Introduction

Hongmei Jin is a notable inventor based in Shanghai, China. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. Her work focuses on the synthesis and application of combretastatin derivatives, which have potential uses in cancer treatment.

Latest Patents

Hongmei Jin holds a patent for "Fluoroalkoxycombretastatin derivatives, method for producing the same and use thereof." This patent describes combretastatin derivatives of formula (I), which are characterized by specific alkyl and fluorine atom configurations. The derivatives exhibit the capability to inhibit the polymerization of microtubules, making them useful in the treatment of tumors and neovascularization.

Career Highlights

Hongmei Jin is currently associated with Zhejiang Dade Pharmaceutical Group Co., Ltd. Her work at this company emphasizes the importance of innovative drug development and the application of her patented compounds in clinical settings.

Collaborations

Hongmei Jin has collaborated with notable colleagues, including Weiping Shen and Jianping Wang. These collaborations have further enhanced her research and development efforts in the pharmaceutical industry.

Conclusion

Hongmei Jin's contributions to pharmaceutical chemistry through her innovative patents and collaborations highlight her role as a key inventor in the field. Her work continues to pave the way for advancements in cancer treatment and drug development.